ArticleThe oncologist2017

Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Results of a Prospective, Noninterventional Study on Routine Treatment Between 2006 and 2012 in Germany.

Peter Dall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.